Nutritional High Completes Psychedelic Science Acquisition

Nutritional High International Inc. (CSE: EAT) said that it has completed the previously announced acquisition of Psychedelic Science Corp. In June, The company announced it was buying Kruzo LLC, a company focused on developing products and conducting research on the psychoactive cacti Peyote. Kruzo also develops other plant-based medicinal products derived from Asian herbal medicine as well as cannabis.

The company didn’t say the value of the deal, but it did plan to raise $1.5 million prior to the acquisition. The company though announced in July that it closed the offering with gross proceeds of only $1.0 million.

“The Transaction is part of our plan to continue to pivot Nutritional High’s focus to its highest-margin product categories,” said CEO John Durfy. “While we continue to develop, manufacture, and sell cannabis products, the PSC acquisition will give us a unique position in this emerging part of the plant-based wellness and medical market.”

The two companies then formed Psychedelic Science Corp. (PSC) to develop health and wellness products while performing research on the therapeutic effects of psychoactive and non-psychoactive plant-based compounds. PSC’s research as well as the initial development of products will be located in Thailand in partnership with Rangsit University (RSU).

Under its agreement with RSU, PSC is developing cultivation and extraction methodologies for cacti, mushrooms, and other plant-based compounds. Further, clinical trials are currently being designed to determine the safety and efficacy of full-plant extract from cacti for the treatment of various indications including, pain, anxiety, and depression. PSC is also working with RSU to source and develop non-psychoactive plant-based wellness products for sale in North America.

RSU is in the process of securing plant material and is expected to commence testing growth rates as compared to the levels of certain desirable alkaloids including the psychoactive compound mescaline. The company expects to cooperate with RSU to develop the commercial supply of certain psychedelic cacti for clinical use in Thailand and abroad. The company is also supporting efforts to legalize psilocybin for medical research purposes and will work with RSU, who has Asian GMP standard grow facilities, to grow various psychedelic mushrooms.

Calyx Brands Sold

Last week, the company said that it was selling Calyx Brands and NH Distribution California Inc. to a company listed as DB12 LLC. The deal was valued at $7 million and included minority ownership in the company DB12.

“Through retaining minority ownership in DB12, Nutritional High will continue to have access to the California market for distribution of our own brands, potentially significant upside associated with ownership of the larger and more integrated DB12 operation, while continuing to improve our balance sheet,” said Durfy. “We are very pleased to partner with DB12 and look forward to a successful partnership.”

Calyx is a distributor of cannabis and cannabis-derived products, which holds a Type 11 distribution license from the Bureau of Cannabis Control of the State of California, which permits the distribution of medical and adult-use cannabis, and cannabis products from manufacturers to dispensaries.

The company said in a statement that the sale of Calyx was a directive established by the company as part of the strategic review process. Through completing a sale to a strategic partner, Calyx will have access to funding and a significant source of flower products to supplement it’s product offering and profitably grow the business.

 

 

 

Debra Borchardt

Debra BorchardtDebra Borchardt

Debra Borchardt is the CEO, Co-Founder, and Editor-In-Chief of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Masters degree in Business Journalism from New York University.


Leave a Reply

Your email address will not be published. Required fields are marked *


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 days

In case you missed it. Weed Talk News 10/16/2020 via @ProCannaMedia

@GreenMarketRpt – 5 days

Green Market Report’s Marijuana Money October 16, 2020

@GreenMarketRpt – 1 week

Green Market Report Wins Big During 2020 Awards Season

Back to Top

You have Successfully Subscribed!